Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosage Reduction of Glucose-Lowering Regimens During Ramadan
NCT04237493Phase 4Completed
- Sponsor
- University of Jordan
- Start
- Feb 2017
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride, vildagliptin, insulin glargine, human insulin in type 2 diabetes mellitus (T2DM), sponsored by University of Jordan. Started Feb 2017; status: completed.
02
Drugs
glimepiridevildagliptininsulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04237493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237493.